Medical Director, Ophthalmology

Company: AAVantgarde

Location: London

Posted: May 10th, 2026

AAVantgarde is a clinical-stage biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases. The company’s lead programs target Stargardt disease and retinitis pigmentosa due to Usher syndrome type 1B—two severe inherited retinal diseases with no approved treatments. With a strong foundation in translational science and a commitment to clinical excellence, AAVantgarde is working to bring transformative therapies to patients.

Position Summary

We are looking for an ambitious, clinically grounded retina specialist to join our growing ocular gene therapy team as a Medical Director. This is a unique opportunity for an early-career retina specialist to play a visible, high-impact role in advancing transformative therapies for inherited retinal diseases (IRDs).

In this role, you will help shape clinical strategy while staying close to the science and the patients. You will work at the intersection of clinical medicine, imaging, and innovative gene therapy development—contributing meaningfully to programs from early development through late-stage trials.

What makes this role compelling?

If you are a candidate with strong hands-on experience in retinal disease management and imaging, we encourage you to apply.

Key Responsibilities

Education and Qualifications

Skills and Capabilities

We will consider applicants from Europe, USA (East Coast) and Canada

#J-18808-Ljbffr
Apply Now